18F-FDG PET predicts pathological response to preoperative chemoradiotherapy in patients with primary rectal cancer: a meta-analysis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Annals of Nuclear Medicine

• Publication date

  2014-03-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12149-014-0837-6PMID 24623152
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New Application of Dual Point 18F-FDG PET/CT in the Evaluation of Neoadjuvant Chemoradiation Response of Locally Advanced Rectal Cancer

  2013cited by this paper
• Early prediction of pathological response in locally advanced rectal cancer based on sequential 18F-FDG PET

  2013cited by this paper
• The role of sequential 18F‐FDG PET/CT in predicting tumour response after preoperative chemoradiation for rectal cancer

  2013cited by this paper
• Neither FDG-PET Nor CT Can Distinguish Between a Pathological Complete Response and an Incomplete Response After Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Prospective Study

  2013cited by this paper
• Predictive value of 18FDG PET-CT for tumour response in patients with locally advanced rectal cancer treated by preoperative chemoradiotherapy

  2013cited by this paper
• Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy

  2013cited by this paper
• 18F-FDG PET/CT-based treatment response evaluation in locally advanced rectal cancer: a prospective validation of long-term outcomes

  2013cited by this paper
• Is the Standardized Uptake Value of FDG-PET/CT Predictive of Pathological Complete Response in Locally Advanced Rectal Cancer Treated with Capecitabine-Based Neoadjuvant Chemoradiation?

  2013cited by this paper
• Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT

  2012cited by this paper
• Neoadjuvant treatment response as an early response indicator for patients with rectal cancer.

  2012cited by this paper
• Positron Emission Tomography for Predicting Pathologic Response After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

  2012cited by this paper
• 18F‐FDG‐PET evaluation of treatment response to neo‐adjuvant therapy in patients with locally advanced rectal cancer: A meta‐analysis

  2012cited by this paper
• Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcome

  2012cited by this paper
• Predicting Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Using 18FDG-PET/CT

  2012cited by this paper
• The Predictive Role of Sequential FDG-PET/CT in Response of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiation

  2012cited by this paper
• The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer

  2012cited by this paper
• FDG-PET Assessment of Rectal Cancer Response to Neoadjuvant Chemoradiotherapy Is Not Associated With Long-Term Prognosis: A Prospective Evaluation

  2012cited by this paper
• PET-based treatment response evaluation in rectal cancer: prediction and validation.

  2012cited by this paper
• Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18 F-FDG PET-CT imaging. A prospective clinical study

  2012cited by this paper
• Prospective study on the FDG-PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer.

  2011cited by this paper
• Long-Term Outcome of Patients with Complete Pathologic Response after Neoadjuvant Chemoradiation for cT3 Rectal Cancer: Implications for Local Excision Surgical Strategies

  2011cited by this paper
• Evaluation of 18F-FDG-PET for Early Detection of Suboptimal Response of Rectal Cancer to Preoperative Chemoradiotherapy: A Prospective Analysis

  2011cited by this paper
• Metabolic Response of Rectal Cancer Assessed by 18-FDG PET Following Chemoradiotherapy is Prognostic for Patient Outcome

  2011cited by this paper
• Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer

  2011cited by this paper
• The metabolic response using 18F-fluorodeoxyglucose-positron emission tomography/computed tomography and the change in the carcinoembryonic antigen level for predicting response to pre-operative chemoradiotherapy in patients with rectal cancer.

  2011cited by this paper
• Neoadjuvant Treatment in Rectal Cancer: Actual Status

  2011cited by this paper
• Preoperative or postoperative therapy for stage II or III rectal cancer: an updated practice guideline.

  2010cited by this paper
• (18)F-FDG PET bio-metabolic monitoring of neoadjuvant therapy effects in rectal cancer: focus on nodal disease characteristics.

  2010cited by this paper
• The value of metabolic imaging to predict tumour response after chemoradiation in locally advanced rectal cancer

  2010cited by this paper
• Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging.

  2010cited by this paper
• Fluoro-Deoxy-Glucose Positron Emission Tomography in Assessing Tumor Response to Preoperative Chemoradiation Therapy for Locally Advanced Rectal Cancer

  2010cited by this paper
• The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer

  2010cited by this paper
• Accuracy of MRI and 18F-FDG PET/CT for Restaging After Preoperative Concurrent Chemoradiotherapy for Rectal Cancer

  2009cited by this paper
• Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review

  2009cited by this paper
• Radiation changes do not interfere with postchemoradiation restaging of patients with rectal cancer by FDG PET/CT before curative surgical therapy.

  2009cited by this paper
• The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery.

  2009cited by this paper
• The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT

  2009cited by this paper
• Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.

  2008cited by this paper
• Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction.

  2008cited by this paper
• Preoperative Radiation Response Evaluated by 18-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival in Locally Advanced Rectal Cancer

  2008cited by this paper
• Pathologic stage is most prognostic of disease‐free survival in locally advanced rectal cancer patients after preoperative chemoradiation

  2008cited by this paper
• PET/CT and Histopathologic Response to Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer

  2008cited by this paper
• Efficacy of Preoperative Combined 18-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography for Assessing Primary Rectal Cancer Response to Neoadjuvant Therapy

  2007cited by this paper
• Detection of recurrent rectal cancer with CT, MRI and PET/CT

  2007cited by this paper
• Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy

  2007cited by this paper
• 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer.

  2006cited by this paper
• Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: Is there a benefit in using functional imaging?

  2005cited by this paper
• Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.

  2005cited by this paper
• Diagnosis of neuroendocrine tumours by retrospective image fusion: is there a benefit?

  2004cited by this paper
• Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET.

  2004cited by this paper
• Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology

  2004cited by this paper
• Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.

  2002cited by this paper
• Restaging of Locally Advanced Carcinoma of the Rectum with MR Imaging after Preoperative Radio-Chemotherapy plus Regional Hyperthermia

  2002cited by this paper
• Restaging of Locally Advanced Carcinoma of the Rectum with MR Imaging after Preoperative Radio-Chemotherapy plus Regional Hyperthermia

  2002cited by this paper
• Pathological features of rectal cancer after preoperative radiochemotherapy

  1997cited by this paper

• The role of FDG uptake to predict the need for re-irradiation in patients treated with 8 Gy (X-ray) single fraction palliative radiotherapy for bone metastases

  2023cites this paper
• ROLE OF CONTEMPORARY IMAGING METHODS IN RADIOTHERAPY PLANNING AND MONITORING OF GYNECOLOGICAL CANCER PATIENTS (REVIEW).

  2023cites this paper
• T2-weighted, apparent diffusion coefficient and 18F-FDG PET histogram analysis of rectal cancer after preoperative chemoradiotherapy

  2021cites this paper
• Imaging-Based Prediction Models

  2020cites this paper
• Response Assessment and Follow-Up by Imaging in Gastrointestinal Tumours

  2020cites this paper
• Evidence-Based PET for Abdominal and Pelvic Tumours

  2020cites this paper
• Multiparametric Imaging for the Locoregional Follow-up of Rectal Cancer

  2020cites this paper
• Predicting response to radiotherapy in tumors with PET/CT: when and how?

  2020cites this paper
• Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2.

  2019cites this paper
• FEP Medical Policy Manual FEP 6.01.26 Oncologic Applications of Positron Emission Tomography Scanning

  2019cites this paper
• Are There Functional Imaging Markers to Consider for Treatment Decision Making

  2018cites this paper
• How Can We Identify Pathologic Complete Responders After Chemoradiotherapy

  2018cites this paper
• Model predicting the ypN0 status after good response to chemoradiotherapy in rectal cancer.

  2018cites this paper
• Monitoring early changes in rectal tumor morphology and volume during 5 weeks of preoperative chemoradiotherapy - An evaluation with sequential MRIs.

  2018cites this paper
• Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in predicting pathological response to preoperative super-selective intra-arterial chemoradiotherapy for advanced squamous cell carcinoma of the mandible

  2018cites this paper
• Individualized threshold for tumor segmentation in 18F-FDG PET/CT imaging: The key for response evaluation of neoadjuvant chemoradiation therapy in patients with rectal cancer?

  2018cites this paper
• Rectal Cancer That Responds to Radiotherapy

  2017cites this paper
• Diagnostic and prognostic value of preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography for colorectal cancer: comparison with conventional computed tomography

  2017cites this paper
• Pitfalls in MRI of rectal cancer: What radiologists need to know and avoid.

  2017cites this paper
• FEP Medical Policy Manual

  2016cites this paper
• Chapter 2 The Important Radiological Prognostic Factors that Influence Neoadjuvant Treatment in Rectal Cancer

  2016influential citation
• Magnetic Resonance Imaging and Other Imaging Modalities in Diagnostic and Tumor Response Evaluation.

  2016cites this paper
• Fluorodeoxyglucose Uptake on Positron Emission Tomography Is a Useful Predictor of Long-Term Pain Control After Palliative Radiation Therapy in Patients With Painful Bone Metastases: Results of a Single-Institute Prospective Study.

  2016cites this paper
• Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.

  2015cites this paper
• Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment

  2015cites this paper
• Value of (18)F-FDG PET for Predicting Response to Neoadjuvant Therapy in Rectal Cancer: Systematic Review and Meta-Analysis.

  2015cites this paper
• Simple criteria to predict margin involvement after chemoradiotherapy and sphincter-sparing for low rectal cancer.

  2015cites this paper
• Molecular Imaging to Plan Radiotherapy and Evaluate Its Efficacy

  2015cites this paper
• Prognostic significance of parameters from pretreatment 18F-FDG PET in hepatocellular carcinoma: a meta-analysis

  2015cites this paper
• The value of liver-based standardized uptake value and other quantitative 18F-FDG PET-CT parameters in neoadjuvant therapy response in patients with locally advanced rectal cancer: correlation with histopathology

  2015cites this paper
• Imaging in rectal cancer with emphasis on local staging with MRI

  2015cites this paper
• Comparison of 18F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer

  2015cites this paper
• Neoadjuvant Rectal (NAR) Score: a New Surrogate Endpoint in Rectal Cancer Clinical Trials

  2015cites this paper
• Rectal cancer: steps towards tailored treatment

  2015cites this paper
• Early prediction of response by ¹⁸F-FDG PET/CT during preoperative therapy in locally advanced rectal cancer: a systematic review.

  2014cites this paper